Syntax Research, Inc.
- SEC CIK
- 0001999827
- Latest filing
- Jul 31, 2026
PFE holding history
Pfizer Inc in every 13F filed by Syntax Research, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 871
- Value
- $21.0K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 871 | $21.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 871 | $24.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 871 | $21.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 871 | $22.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 871 | $21.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 871 | $22.1K | <0.1% | −577−39.8% | Reduced | Holders |
| Q4 2024 | 1,448 | $38.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,448 | $41.9K | <0.1% | −650−31.0% | Reduced | Holders |
| Q2 2024 | 2,098 | $58.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,098 | $58.2K | <0.1% | −350−14.3% | Reduced | Holders |
| Q4 2023 | 2,448 | $70.5K | 0.1% | +181+8.0% | Added | Holders |
| Q3 2023 | 2,267 | $75.2K | 0.1% | – | No prior filing | Holders |